Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1993-10-04
1995-03-14
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424457, 424458, 424462, 424463, 424456, A61K 962
Patent
active
053975740
ABSTRACT:
A pharmaceutical composition for oral administration of potassium salt in a form not irritating to the gastrointestinal mucosa comprises tablets or capsules of micropellets of a potassium salt, such as potassium chloride. The micropellets are coated with a permeable polymer comprising a low viscosity (10 cp.) ethylcellulose in combination with triacetin. This coating provides a strong film resistant to breakage during formation of tablets and filling of capsules. The protective coating of the micropellets prevents the early release of potassium ions, while the tablet or capsule disintegrates and the micropellets are dispersed within the lumen of the gastrointestinal tract. As water passes through the permeable but insoluble coating, potassium ions are gradually eluted into the fluid of the tract over a period of many hours, thereby allowing time for the ions to be absorbed from the tract before high, irritating ion concentrations can form.
REFERENCES:
patent: 4798724 (1989-01-01), Khanna
patent: 4863743 (1989-09-01), Hsiao
patent: 4946685 (1990-08-01), Edgren et al.
patent: 5035898 (1991-07-01), Chang
patent: 5200195 (1993-04-01), Dong et al.
patent: 5260069 (1993-11-01), Chen
Baum et al. Total Body Exchangeable Potassium . . . American Heart Journal 58(2) Jul. 1959 (53-58).
Andrx Pharmaceuticals Inc.
Benston, Jr. William E.
Blum Alvin S.
Page Thurman K.
LandOfFree
Controlled release potassium dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release potassium dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release potassium dosage form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-712185